27th Oct 2008 07:00
27 October 2008
HENDERSON MORLEY PLC
(AIM: HML)
POSTING OF ANNUAL REPORT AND ACCOUNTS
The Board of Henderson Morley Plc ("Henderson Morley" or "the Company"), the AIM quoted drug discovery company, announces that the Company's Annual Report and Accounts for the year to 30 April 2008, has been posted to shareholders today.
The Annual Report and Accounts are also available for download from the Company's website http://www.henderson-morley.com.
---ENDS---
ENQUIRIES:
HENDERSON MORLEY PLC 0121 442 4600
Andrew Knight, Chairman
BISHOPSGATE COMMUNICATIONS LTD 0207 562 3350 Maxine Barnes Nick Rome
BREWIN DOLPHIN INVESTMENT BANKING 0113 241 0126
Neil Baldwin
HYBRIDAN LLP 0203 159 5085
Claire Noyce/Stephen Austin
Further information on Henderson Morley plc can be accessed through the Company's website at www.henderson-morley.com
Notes to Editors:
Henderson Morley was founded in 1996 with the objective of developing its anti viral application (Ionic Contra Viral Therapy (ICVT). ICVT is the Lead Platform and has been developed in-house and HML wholly owns the patent IPR.
Related Shares:
HML.L